MYN: Analyzer, Medical Image
What it covers
For information on the MYN device, please see: https://www.federalregister.gov/documents/2020/01/22/2020-00494/radiology-devices-reclassification-of-medical-image-analyzers
FDA’s definition of product code MYN, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252486 | ChestView US (1.1) | Gleamer | Sep 9, 2026 | Traditional |
| K261059 | Overjet Multi-Image Caries and Charting Assist | Overjet, Inc. | Aug 6, 2026 | Traditional |
| K260851 | Better Diagnostics Dental Assist (BDDA) Version 1.0 | Better Diagnostics AI Corp. | Jul 15, 2026 | Traditional |
| K252953 | Velmeni for Dentists (V4D) Endo-Perio | Velmeni, Inc. | May 11, 2026 | Traditional |
| K251934 | qXR-Detect | Qure.Ai Technologies | Jan 16, 2026 | Traditional |
| K252934 | Diagnocat | DGNCT, LLC | Jan 15, 2026 | Traditional |
| K253009 | DS Core Detect | Dentsply Sirona, Inc. | Jan 7, 2026 | Traditional |
| K252086 | DTX Studio Assist | Nobel Biocare C/O Medicim NV | Nov 17, 2025 | Traditional |
| K250525 | Second Opinion® Panoramic | Pearl, Inc. | Nov 14, 2025 | Traditional |
| K250264 | SugarBug (1.x) | Bench7, Inc. | Nov 7, 2025 | Traditional |
Clearances by year
40 MYN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 7 | 128 |
| 2025 | 14 | 210 |
| 2024 | 2 | 172 |
| 2023 | 10 | 229 |
| 2022 | 5 | 273 |
| 2021 | 2 | 292 |
Who submits
21 applicants cleared a MYN device since 2011. 75% of the clearances went to applicants in United States, then France (8%), India (8%) and Belgium (3%). By type: Traditional 100%.
| Applicant | Clearances since 2011 |
|---|---|
| Overjet, Inc. | 6 |
| Pearl, Inc. | 6 |
| Imagen Technologies, Inc. | 4 |
| Velmeni, Inc. | 3 |
| Videahealth, Inc. | 3 |
| Better Diagnostics AI Corp. | 2 |
| Qure.Ai Technologies | 2 |
| AZmed | 1 |
How FDA classifies it
Class II (special controls). The special controls for this device are:
(1) Design verification and validation must include:
(i) A detailed description of the image analysis algorithms including a description of the algorithm inputs and outputs, each major component or block, and algorithm limitations.
(ii) A detailed description of pre-specified performance testing methods and dataset(s) used to assess whether the device will improve reader performance as intended and to characterize the standalone device performance. Performance testing includes one or more standalone tests, side-by-side comparisons, or a reader study, as applicable.
(iii) Results from performance testing that demonstrate that the device improves reader performance in the intended use population when used in accordance with the instructions for use. The performance assessment must be based on appropriate diagnostic accuracy measures (e.g., receiver operator characteristic plot, sensitivity, specificity, predictive value, and diagnostic likelihood ratio). The test dataset must contain a sufficient number of cases from important cohorts (e.g., subsets defined by clinically relevant confounders, effect modifiers, concomitant diseases, and subsets defined by image acquisition characteristics) such that the performance estimates and confidence intervals of the device for these individual subsets can be characterized for the intended use population and imaging equipment.
(iv) Appropriate software documentation (e.g., device hazard analysis; software requirements specification document; software design specification document; traceability analysis; description of verification and validation activities including system level test protocol, pass/fail criteria, and results; and cybersecurity).
(2) Labeling must include the following:
(i) A detailed description of the patient population for which the device is indicated for use.
(ii) A detailed description of the intended reading protocol.
(iii) A detailed description of the intended user and user training that addresses appropriate reading protocols for the device.
(iv) A detailed description of the device inputs and outputs.
(v) A detailed description of compatible imaging hardware and imaging protocols.
(vi) Discussion of warnings, precautions, and limitations must include situations in which the device may fail or may not operate at its expected performance level (e.g., poor image quality or for certain subpopulations), as applicable.
(vii) Device operating instructions.
(viii) A detailed summary of the performance testing, including: test methods, dataset characteristics, results, and a summary of sub-analyses on case distributions stratified by relevant confounders, such as lesion and organ characteristics, disease stages, and imaging equipment.
From 21 CFR 892.2070. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 892.2070 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MYN clearances declared.
Ask about MYN
Questions about MYN
What is FDA product code MYN?
Product code MYN, “Analyzer, Medical Image” in FDA's classification database, is a Class II device type under 21 CFR 892.2070 (medical image analyzer), reviewed by FDA's Radiology panel. FDA's 510(k) database lists 40 clearances under MYN, 40 of them since 2011.
How many 510(k) clearances are there under MYN?
FDA’s 510(k) database listed 40 clearances under MYN as of Oct 29, 2026, 40 of them decided since 2011; the most recent decision was Sep 9, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MYN 510(k)?
For the 21 MYN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 196 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MYN clearances?
Since 2011: Overjet, Inc. (6), Pearl, Inc. (6), Imagen Technologies, Inc. (4), Velmeni, Inc. (3) and Videahealth, Inc. (3). 21 applicants have cleared a MYN device in that time.